Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

BP Control and Long-Term Risk of ESRD and Mortality.

Ku E, Gassman J, Appel LJ, Smogorzewski M, Sarnak MJ, Glidden DV, Bakris G, GutiƩrrez OM, Hebert LA, Ix JH, Lea J, Lipkowitz MS, Norris K, Ploth D, Pogue VA, Rostand SG, Siew ED, Sika M, Tisher CC, Toto R, Wright JT Jr, Wyatt C, Hsu CY.

J Am Soc Nephrol. 2017 Feb;28(2):671-677. doi: 10.1681/ASN.2016030326. Epub 2016 Aug 11.

2.

Relationship between ambulatory BP and clinical outcomes in patients with hypertensive CKD.

Gabbai FB, Rahman M, Hu B, Appel LJ, Charleston J, Contreras G, Faulkner ML, Hiremath L, Jamerson KA, Lea JP, Lipkowitz MS, Pogue VA, Rostand SG, Smogorzewski MJ, Wright JT, Greene T, Gassman J, Wang X, Phillips RA; African American Study of Kidney Disease and Hypertension (AASK) Study Group.

Clin J Am Soc Nephrol. 2012 Nov;7(11):1770-6. doi: 10.2215/CJN.11301111. Epub 2012 Aug 30.

3.

Nurse-led disease management for hypertension control in a diverse urban community: a randomized trial.

Hebert PL, Sisk JE, Tuzzio L, Casabianca JM, Pogue VA, Wang JJ, Chen Y, Cowles C, McLaughlin MA.

J Gen Intern Med. 2012 Jun;27(6):630-9. doi: 10.1007/s11606-011-1924-1. Epub 2011 Dec 6.

4.

Limitations of analyses based on achieved blood pressure: lessons from the African American study of kidney disease and hypertension trial.

Davis EM, Appel LJ, Wang X, Greene T, Astor BC, Rahman M, Toto R, Lipkowitz MS, Pogue VA, Wright JT Jr; African American Study of Kidney Disease and Hypertension Research Collaborative Group.

Hypertension. 2011 Jun;57(6):1061-8. doi: 10.1161/HYPERTENSIONAHA.111.169367. Epub 2011 May 9.

5.

Intensive blood-pressure control in hypertensive chronic kidney disease.

Appel LJ, Wright JT Jr, Greene T, Agodoa LY, Astor BC, Bakris GL, Cleveland WH, Charleston J, Contreras G, Faulkner ML, Gabbai FB, Gassman JJ, Hebert LA, Jamerson KA, Kopple JD, Kusek JW, Lash JP, Lea JP, Lewis JB, Lipkowitz MS, Massry SG, Miller ER, Norris K, Phillips RA, Pogue VA, Randall OS, Rostand SG, Smogorzewski MJ, Toto RD, Wang X; AASK Collaborative Research Group.

N Engl J Med. 2010 Sep 2;363(10):918-29. doi: 10.1056/NEJMoa0910975.

6.

Influence of concomitant prednisolone on trimethoprim-associated hyperkalaemia.

Mohan S, Jaitly M, Pogue VA, Cheng JT.

J Antimicrob Chemother. 2009 Oct;64(4):850-2. doi: 10.1093/jac/dkp280. Epub 2009 Aug 4.

PMID:
19656784
7.

Acute bilateral renal infarction secondary to cocaine-induced vasospasm.

Madhrira MM, Mohan S, Markowitz GS, Pogue VA, Cheng JT.

Kidney Int. 2009 Sep;76(5):576-80. doi: 10.1038/ki.2008.550. Epub 2008 Oct 22. No abstract available.

8.

Hypokalemia during sickle cell crises apparently due to intermittent mineralocorticoid excess.

Jaitly M, Mohan S, Park CM, Anderson HL, Cheng JT, Pogue VA.

Am J Kidney Dis. 2008 Feb;51(2):319-25. doi: 10.1053/j.ajkd.2007.10.031. No abstract available.

PMID:
18215710
9.

Proteinuria lowers the risk of amphotericin B-associated hypokalaemia.

Mohan S, Ahmed S, Alimohammadi B, Jaitly M, Cheng JT, Pogue VA.

J Antimicrob Chemother. 2007 Sep;60(3):690-3. Epub 2007 Jun 27.

PMID:
17597057
10.

Unusual biopsy findings in a hepatitis C-infected white man with cryoglobulinemia, purpuric rash, and renal failure.

Mohan S, Jaitly M, Cheng JT, D'Agati VD, Pogue VA.

Am J Kidney Dis. 2006 Sep;48(3):513-7. No abstract available.

PMID:
16931228
11.

Kidney disease physician workforce: where is the emerging pipeline?

Pogue VA, Norris KC, Dillard MG.

J Natl Med Assoc. 2002 Aug;94(8 Suppl):39S-44S.

12.

Hepatitis C virus-associated glomerular disease in patients with human immunodeficiency virus coinfection.

Cheng JT, Anderson HL Jr, Markowitz GS, Appel GB, Pogue VA, D'Agati VD.

J Am Soc Nephrol. 1999 Jul;10(7):1566-74.

14.

Cocaine-associated acute myoglobinuric renal failure.

Pogue VA, Nurse HM.

Am J Med. 1989 Feb;86(2):183-6.

PMID:
2913784

Supplemental Content

Loading ...
Support Center